Drug Type ASO |
Synonyms- |
Target |
Mechanism SHANK3 modulators(SH3 and multiple ankyrin repeat domains 3 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Phelan-McDermid syndrome | Preclinical | AU | - |